US Stock MarketDetailed Quotes

AstraZeneca (AZN)

Watchlist
  • 187.720
  • +3.180+1.72%
Close May 13 16:00 ET
  • 186.910
  • -0.810-0.43%
Pre 07:42 ET
291.13BMarket Cap28.27P/E (TTM)

AstraZeneca (AZN) Key Financial Indicators

AZN Earnings per Share (EPS)

According to the latest financial report of AstraZeneca, the latest earnings per share (TTM) for the company is 1.97. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

AZN Free Cash Flow (FCF)

Interested in knowing about AstraZeneca's free cash flow? The latest report shows it as 1.82B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

AZN Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of AstraZeneca shows that the company's current ratio is 0.91, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

AZN Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of AstraZeneca, the quick ratio is 0.67, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

AZN Return on Equity (ROE)

Want to learn more about the financial health of AstraZeneca? The latest ROE figure is 6.51%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

AZN Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of AstraZeneca, the total asset return on investment (ROA) is 2.70%.

Currency: USD

Quarterly

Loading...

AZN Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check AstraZeneca's latest financial report to see how their gross margin is doing - currently at 82.48%.

Currency: USD

Quarterly

Loading...

AZN Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of AstraZeneca, the net profit margin is 20.15%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More